Amphastar Pharmaceuticals (AMPH) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Amphastar Pharmaceuticals Revenue Highlights


Latest Revenue (Y)

$593.24M

Latest Revenue (Q)

$182.39M

Main Segment (Y)

Active Pharmaceutical Ingredient Segment

Main Geography (Y)

U

Amphastar Pharmaceuticals Revenue by Period


Amphastar Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$593.24M18.89%
2022-12-31$498.99M13.98%
2021-12-31$437.77M25.13%
2020-12-31$349.85M8.53%
2019-12-31$322.36M9.40%
2018-12-31$294.67M22.69%
2017-12-31$240.18M-5.87%
2016-12-31$255.16M1.45%
2015-12-31$251.52M19.51%
2014-12-31$210.46M-8.37%
2013-12-31$229.68M12.41%
2012-12-31$204.32M72.63%
2011-12-31$118.36M-

Amphastar Pharmaceuticals generated $593.24M in revenue during NA 2023, up 18.89% compared to the previous quarter, and up 201.33% compared to the same period a year ago.

Amphastar Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-06-30$182.39M6.14%
2024-03-31$171.84M-3.52%
2023-12-31$178.10M-1.36%
2023-09-30$180.56M23.91%
2023-06-30$145.71M4.06%
2023-03-31$140.02M3.70%
2022-12-31$135.02M12.40%
2022-09-30$120.13M-2.70%
2022-06-30$123.47M2.57%
2022-03-31$120.37M-0.43%
2021-12-31$120.89M7.74%
2021-09-30$112.20M10.36%
2021-06-30$101.66M-1.32%
2021-03-31$103.02M7.40%
2020-12-31$95.92M14.97%
2020-09-30$83.43M-2.77%
2020-06-30$85.81M1.32%
2020-03-31$84.69M1.57%
2019-12-31$83.38M4.05%
2019-09-30$80.14M1.38%
2019-06-30$79.05M-0.93%
2019-03-31$79.79M-11.04%
2018-12-31$89.69M18.73%
2018-09-30$75.54M6.34%
2018-06-30$71.04M21.66%
2018-03-31$58.39M-3.33%
2017-12-31$60.40M4.29%
2017-09-30$57.92M-11.15%
2017-06-30$65.19M15.03%
2017-03-31$56.67M-10.82%
2016-12-31$63.54M-1.06%
2016-09-30$64.22M-5.60%
2016-06-30$68.03M14.60%
2016-03-31$59.37M-22.81%
2015-12-31$76.91M20.42%
2015-09-30$63.87M18.60%
2015-06-30$53.85M-5.33%
2015-03-31$56.89M1.81%
2014-12-31$55.88M-6.42%
2014-09-30$59.71M21.85%
2014-06-30$49.00M6.83%
2014-03-31$45.87M-16.41%
2013-12-31$54.88M-7.49%
2013-09-30$59.32M-5.13%
2013-06-30$62.52M18.05%
2013-03-31$52.96M-

Amphastar Pharmaceuticals generated $182.39M in revenue during Q2 2024, up 6.14% compared to the previous quarter, and up 130.26% compared to the same period a year ago.

Amphastar Pharmaceuticals Revenue Breakdown


Amphastar Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 20Dec 19Dec 18
Active Pharmaceutical Ingredient Segment$18.48M$20.36M$23.61M

Amphastar Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 20: Active Pharmaceutical Ingredient Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18Jun 18Mar 18
Active Pharmaceutical Ingredient Segment$6.94M$5.14M$8.12M$2.10M$4.87M$3.39M$5.39M$4.41M$5.31M$5.25M$3.78M$7.80M$5.28M-
Finished Pharmaceutical Products Segment----------$82.93M---

Amphastar Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Jun 21: Active Pharmaceutical Ingredient Segment (100.00%).

Amphastar Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 20Dec 19Dec 18
U$333.09M$304.90M$279.12M
Active Pharmaceutical Ingredient Segment$18.48M--
C$3.16M$1.48M-

Amphastar Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 20: U (93.90%), Active Pharmaceutical Ingredient Segment (5.21%), and C (0.89%).

Quarterly Revenue by Country

CountryJun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Sep 18Jun 18Mar 18
Active Pharmaceutical Ingredient Segment$6.94M------------
U$95.19M$99.17M$90.72M$79.41M$81.90M$81.06M$77.59M$76.07M$74.78M$76.46M$72.48M$68.56M$53.10M
C$1.13M$1.12M$679.00K$1.96M$295.00K$228.00K$438.00K$59.00K$984.00K----

Amphastar Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Jun 21: U (92.19%), Active Pharmaceutical Ingredient Segment (6.72%), and C (1.09%).

Amphastar Pharmaceuticals Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
NBIXNeurocrine Biosciences$1.89B$622.10M
ALKSAlkermes$1.66B$378.14M
PBHPrestige Consumer Healthcare$1.13B$267.14M
PAHCPhibro Animal Health$977.89M$263.22M
EVOEvotec SE$781.43M$208.73M
PCRXPacira BioSciences$674.98M$178.02M
SUPNSupernus Pharmaceuticals$607.52M$168.32M
AMPHAmphastar Pharmaceuticals$593.24M$182.39M
COLLCollegium Pharmaceutical$566.77M$144.92M
ANIPANI Pharmaceuticals$486.82M$138.04M
IRWDIronwood Pharmaceuticals$442.74M$94.40M
EGRXEagle Pharmaceuticals$316.61M$64.65M
EOLSEvolus$199.72M$66.22M
DCPHDeciphera Pharmaceuticals$163.36M$45.00M

AMPH Revenue FAQ


Amphastar Pharmaceuticals's yearly revenue for 2023 was $593.24M, representing an increase of 18.89% compared to 2022. The company's yearly revenue for 2022 was $498.99M, representing an increase of 13.98% compared to 2021. AMPH's yearly revenue for 2021 was $437.77M, representing an increase of 25.13% compared to 2020.

Amphastar Pharmaceuticals's quarterly revenue for Q2 2024 was $182.39M, a 6.14% increase from the previous quarter (Q1 2024), and a 25.17% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $171.84M, a -3.52% decrease from the previous quarter (Q4 2023), and a 22.72% increase year-over-year (Q1 2023). AMPH's quarterly revenue for Q4 2023 was $178.1M, a -1.36% decrease from the previous quarter (Q3 2023), and a 31.91% increase year-over-year (Q4 2022).

Amphastar Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 35.51%, and for the last 5 years (2019-2023) was 84.03%.

Amphastar Pharmaceuticals's revenue streams in c 20 are Active Pharmaceutical Ingredient Segment

For the fiscal year ending Dec 20, the largest source of revenue of Amphastar Pharmaceuticals was Active Pharmaceutical Ingredient Segment. This segment made a revenue of $18.48M, representing 100.00% of the company's total revenue.